Telik (TELK) Move "Very Silly" - Feuerstein

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 7/25/2026

1. INTC
2. DECK
3. META
4. AMD
5. INFY

6. TMUS
7. SPY
8. UNP
9. GOOGL
10. RNG

January 11, 2013 1:33 PM EST

Price: $1.46 --0%

Overall Analyst Rating:
SELL (= Flat)

Biotech watcher Adam Feuerstein said "very silly" for Telik Inc. (NASDAQ: TELK) to be up 60% on orphan drug designation.

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!